Earnings recap โ€” May 14, 2026 โ€” Regular session


Result: โœ… BEAT โ€” AI Infrastructure Cycle Confirmed Again

EstimateReportedSurprise
Revenue growth~+15% YoY+18.4% YoYโœ… Significant beat
FY2026 EPS guidanceโ€”$2.30โ€“$2.50โœ… Raised
Q2 FY2026 EPS guideโ€”$0.51โ€“$0.55โ€”

Why It Matters

HPEโ€™s result is the second major AI infrastructure beat in 48 hours โ€” following CSCOโ€™s monster Q3 on Wednesday. The pattern is clear: enterprise infrastructure spending on AI is accelerating, and both the networking (CSCO) and the compute/server (HPE) layers are benefiting.

The Juniper milestone is the real story. HPE paid $16B for Juniper Networks to compete directly with Cisco in AI-driven networking. The fact that Juniper is now included in normalized Q1 earnings signals the integration is on track โ€” this was the key execution risk that had been discounting HPE shares.

AI servers: Demand for HPEโ€™s AI server line (GreenLake, ProLiant AI-optimized) is a direct beneficiary of hyperscaler buildout. Revenue growing +18.4% YoY confirms orders are flowing.

China exit: HPE sold its remaining stake in H3C Technologies for $900M โ€” a clean exit from China exposure, reducing geopolitical risk. Given Xi-Taiwan tensions this week, this move looks prescient.


Guidance Watch


Context

HPE stock entered the day at ~$32.07. The +4.63% move to $33.57 came alongside CSCOโ€™s historic +16.5% session โ€” both AI infrastructure names running together.

The CSCO + HPE double beat is a powerful signal: Two of the top enterprise infrastructure names reported back-to-back and both crushed estimates. Arista Networks (ANET) is next in line as a natural beneficiary โ€” not yet reported.


Read-Throughs

NameSignal
ANETArista Networks โ€” direct networking competitor; CSCO+HPE beats raise Arista expectations
DELLAI server competitor โ€” positive read-through on enterprise AI demand
NVDAHyperscaler AI capex driving both networking and compute โ€” positive
CSCOAlready +16.5% this week; HPE confirms the sector thesis

Ray โ€” signals.themenonlab.com | Not financial advice. For informational purposes only.